Chia Tai Enterprises International Ltd 03839
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 0.70
- Day Range
- HKD 0.70–0.70
- 52-Week Range
- HKD 0.65–2.30
- Bid/Ask
- HKD 0.72 / HKD 0.76
- Market Cap
- HKD 173.32 Mil
- Volume/Avg
- 1,000 / 59,331
Key Statistics
- Price/Earnings (Normalized)
- 45.86
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chia Tai Enterprises International Ltd engaged in the manufacture and sale of chlortetracycline (CTC) products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and other related products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China, Asia Pacific (excluding mainland China), Americas, Europe, and Others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,000
Comparables
Valuation
|
Metric
|
03839
|
00617
|
00105
|
|---|---|---|---|
Price/Earnings (Normalized) | 45.86 | — | 15.18 |
Price/Book Value | 0.09 | 0.08 | 0.24 |
Price/Sales | 0.13 | 0.30 | 6.45 |
Price/Cash Flow | — | — | 11.43 |
Price/Earnings
03839
00617
00105
Financial Strength
|
Metric
|
03839
|
00617
|
00105
|
|---|---|---|---|
Quick Ratio | 1.15 | 0.33 | 2.94 |
Current Ratio | 1.55 | 1.55 | 3.04 |
Interest Coverage | 1.92 | −0.56 | 1.36 |
Quick Ratio
03839
00617
00105
Profitability
|
Metric
|
03839
|
00617
|
00105
|
|---|---|---|---|
Return on Assets (Normalized) | 0.52% | −3.87% | −0.04% |
Return on Equity (Normalized) | 0.83% | −13.76% | −0.05% |
Return on Invested Capital (Normalized) | 0.76% | −2.09% | −0.14% |
Return on Assets
03839
00617
00105
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hsyfxhgwjj | Xcyvtf | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Wsmrtsybgh | Xsdtk | $68.9 Bil | |
HLN
| Haleon PLC ADR | Xvdmynjdb | Ymts | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vtjclyn | Gbg | $14.8 Bil | |
VTRS
| Viatris Inc | Zlzpwmzsv | Spxmc | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Smlsjty | Sdbs | $11.9 Bil | |
CTLT
| Catalent Inc | Ypnwbsbz | Tkyhm | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gtwhcjnk | Lzsdr | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Pyhrtqq | Dvwtt | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jtlnfhwm | Jjdhzgj | $3.5 Bil |